Our previous studies have shown that cross-linkage of freshly isolated T cells with PSCA+ tumor cells via the CD3 complex using the scBsTaFv CD3-PSCA(MB1) results in efficient activation of both CD8+ and CD4+ T cells. This evidence concerns the gene CD8A and neoplasm.